Generalized high bone mineral density on bone density scanning: a case of gastric carcinoma with bone metastasis

References

• Abrams HL, Spiro R, Goldstein N. Metastases in carcinoma; analysis of 1000 autopsied cases. Cancer. 1950;3:74–85.
   PubMed Web of Science ®Google Scholar
• Hughes ES, Johnson WR, McDermott FT, et al. Gastric cancer and survival. Med J Aust. 1984;140:147–148.
   Google Scholar
• Kwon JY, Yun J, Kim HJ, et al. Clinical outcome of gastric cancer patients with bone marrow metastases. Cancer Res Treat. 2011;43:244–249.
   Google Scholar
• Choi CW, Lee DS, Chung JK, et al. Evaluation of bone metastases by Tc-99m MDP imaging in patients with stomach cancer. Clin Nucl Med. 1995;20:310–314.
   PubMed Web of Science ®Google Scholar
• Park HS, Rha SY, Kim HS, et al. A prognostic model to predict clinical outcome in gastric cancer patients with bone metastasis. Oncology. 2011;80:142–150.
   PubMed Web of Science ®Google Scholar
• Braun S, Kentenich C, Janni W, et al. Lack of effect of adjuvant chemotherapy on the elimination of single dormant tumor cells in bone marrow of high-risk breast cancer patients. J Clin Oncol. 2000;18:80–86.
   PubMed Web of Science ®Google Scholar
• Paget S. The distribution of secondary growths in cancer of the breast. 1889. Cancer Metastasis Rev. 1989;8:98–101.
   PubMed Web of Science ®Google Scholar
• Xiao W, Li S, Pacios S, et al. Bone remodeling under pathological conditions. Front Oral Biol. 2016;18:17–27.
   PubMedGoogle Scholar
• Uchida T, Shikata T, Shimizu SI, et al. Gonadotropin and alkaline phosphatase producing occult gastric carcinoma with widespread metastasis of generalized bone. Cancer. 1981;48:140–150.
   PubMed Web of Science ®Google Scholar
• Lee J, Lim T, Uhm JE, et al. Prognostic model to predict survival following first-line chemotherapy in patients with metastatic gastric adenocarcinoma. Ann Oncol. 2007;18:886–891.
   PubMed Web of Science ®Google Scholar
• Kim JG, Ryoo BY, Park YH, et al. Prognostic factors for survival of patients with advanced gastric cancer treated with cisplatin-based chemotherapy. Cancer Chemother Pharmacol. 2008;61:301–307.
   PubMed Web of Science ®Google Scholar
• Ahn JB, Ha TK, Kwon SJ. Bone metastasis in gastric cancer patients. J Gastric Cancer. 2011;11:38–45.
   PubMedGoogle Scholar
• Pasquini E, Gianni L, Aitini E, et al. Acute disseminated intravascular coagulation syndrome in cancer patients. Oncology. 1995;52:505–508.
   PubMed Web of Science ®Google Scholar
• Etoh T, Baba H, Taketomi A, et al. Diffuse bone metastasis with hematologic disorders from gastric cancer: clinicopathological features and prognosis. Oncol Rep. 1999;6:601–605.
   PubMed Web of Science ®Google Scholar
• McQuay HJ, Collins SL, Carroll D, et al. Radiotherapy for the palliation of painful bone metastases. Cochrane Database Syst Rev. 2000;2:CD001793.
   Google Scholar
• Webb A, Cunningham D, Scarffe JH, et al. Randomized trial comparing epirubicin, cisplatin, and fluorouracil versus fluorouracil, doxorubicin, and methotrexate in advanced esophagogastric cancer. J Clin Oncol. 1997;15:261–267.
   PubMed Web of Science ®Google Scholar
• Waters JS, Norman A, Cunningham D, et al. Long-term survival after epirubicin, cisplatin and fluorouracil for gastric cancer: results of a randomized trial. Br J Cancer. 1999;80:269–272.
   PubMed Web of Science ®Google Scholar
• Vanhoefer U, Rougier P, Wilke H, et al. Final results of a randomized phase III trial of sequential high-dose methotrexate, fluorouracil, and doxorubicin versus etoposide, leucovorin, and fluorouracil versus infusional fluorouracil and cisplatin in advanced gastric cancer: a trial of the European Organization for Research and Treatment of Cancer Gastrointestinal Tract Cancer Cooperative Group. J Clin Oncol. 2000;18:2648–2657.
   PubMed Web of Science ®Google Scholar
• Ross P, Nicolson M, Cunningham D, et al. Prospective randomized trial comparing mitomycin, cisplatin, and protracted venous-infusion fluorouracil (PVI 5-FU) with epirubicin, cisplatin, and PVI 5-FU in advanced esophagogastric cancer. J Clin Oncol. 2002;20:1996–2004.
   PubMed Web of Science ®Google Scholar
• Ohtsu A, Shimada Y, Shirao K, et al. Randomized phase III trial of fluorouracil alone versus fluorouracil plus cisplatin versus uracil and tegafur plus mitomycin in patients with unresectable, advanced gastric cancer: The Japan Clinical Oncology Group Study (JCOG9205). J Clin Oncol. 2003;21:54–59.
   PubMed Web of Science ®Google Scholar
• Sumpter K, Harper-Wynne C, Cunningham D, et al. Report of two protocol planned interim analyses in a randomised multicentre phase III study comparing capecitabine with fluorouracil and oxaliplatin with cisplatin in patients with advanced oesophagogastric cancer receiving ECF. Br J Cancer. 2005;92:1976–1983.
   PubMed Web of Science ®Google Scholar
• Chau I, Norman AR, Cunningham D, et al. Multivariate prognostic factor analysis in locally advanced and metastatic esophago-gastric cancer–pooled analysis from three multicenter, randomized, controlled trials using individual patient data. J Clin Oncol. 2004;22:2395–2403.
   PubMed Web of Science ®Google Scholar
• Andreyev HJ, Norman AR, Oates J, et al. Why do patients with weight loss have a worse outcome when undergoing chemotherapy for gastrointestinal malignancies? Eur J Cancer. 1998;34:503–509.
   PubMed Web of Science ®Google Scholar
• Brown JE, Cook RJ, Major P, et al. Bone turnover markers as predictors of skeletal complications in prostate cancer, lung cancer, and other solid tumors. J Natl Cancer Inst. 2005;97:59–69.
   PubMed Web of Science ®Google Scholar
• Lim SM, Kim YN, Park KH, et al. Bone alkaline phosphatase as a surrogate marker of bone metastasis in gastric cancer patients. BMC Cancer. 2016;16:385.
   PubMed Web of Science ®Google Scholar
• Fung WP, Barr A. Fulminant disseminated intravascular coagulation in advanced gastric carcinoma. Am J Gastroenterol. 1979;71:210–212.
   PubMed Web of Science ®Google Scholar
• Kobayashi M, Okabayashi T, Sano T, et al. Metastatic bone cancer as a recurrence of early gastric cancer–characteristics and possible mechanisms. Wjg. 2005;11:5587–5591.
   PubMed Web of Science ®Google Scholar
• Kim HS, Yi SY, Jun HJ, et al. Clinical outcome of gastric cancer patients with bone marrow metastases. Oncology. 2007;73:192–197.
   PubMed Web of Science ®Google Scholar
• Nishidoi H, Koga S. [Clinicopathological study of gastric cancer with bone metastasis]. Gan To Kagaku Ryoho. 1987;14:1717–1722.
   PubMedGoogle Scholar
• Rosenthal DI. Radiologic diagnosis of bone metastases. Cancer. 1997;80:1595–1607.
   PubMed Web of Science ®Google Scholar